Assessment of Artificial Intelligence software for automatic screening of Diabetic Retinopathy based on fundus photographs in Melanoderm subjects.

Purpose: To assess the Gaiha Prio Retino +™Artificial Intelligence (AI) software for detecting diabetic retinopathy (DR).

Methods: This prospective study was conducted from March 1, 2021 to September 30, 2022 in the Ophthalmology department of the Abass NDAO Hospital (Dakar, Senegal). The clinical classification of DR was based on American Academy of Ophthalmology's.